← Leaderboards
Michael Weisman
University Of Texas Hlth Sci Ctr Houston
$1,730,671
Attributed
$1,730,671
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $380.4K · FY2012–16$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,730,671 · 1
By mechanism
P01$1,730,671 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- John Duffin Reveille$11,528,689
- Kazim A Sheikh$11,409,209
- Ponnada A Narayana$19,017,319
- Frank C Arnett$15,803,618
- Shervin Assassi$2,337,912
Others in their field
Top investigators on “Age-Years”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$198,045,446
- Lawrence Corey · Fred Hutchinson Cancer Center$197,946,944
- Leonardo Trasande · New York University School Of Medicine$53,130,146
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$44,852,133
- Walter N Kernan · Yale University$42,197,025
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$39,632,777
Research focus
Age-YearsAmericanAnkylosing SpondylitisAnkylosisAutomobile DrivingBaseBoneBone DiseasesCanadaCardiacCardiovascular Risk FactorCardiovascular SystemCessation Of LifeCharacteristicsChronicCohortCollaborationsCoupledCreativenessData AnalysesDatabasesData CollectionDesignAdult
Grant awards (5)
Large scale mltinational collaboration for risk of progression and outcome in AS$357,894
P01 · FY2016 · AR · contact PI
Large scale mltinational collaboration for risk of progression and outcome in AS$357,894
P01 · FY2015 · AR · contact PI
Large scale mltinational collaboration for risk of progression and outcome in AS$332,536
P01 · FY2014 · AR · contact PI
Large scale mltinational collaboration for risk of progression and outcome in AS$301,995
P01 · FY2013 · AR · contact PI
Large scale mltinational collaboration for risk of progression and outcome in AS$380,352
P01 · FY2012 · AR · contact PI